ロード中...
Differentiation of Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis by PAM4 Immunohistochemistry
CONTEXT: PAM4 is a monoclonal antibody that shows high specificity for pancreatic ductal adenocarcinoma (PDAC) and its neoplastic precursor lesions. A PAM4-based serum immunoassay is able to detect 71% of early-stage patients and 91% with advanced disease. However, approximately 20% of patients diag...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4037743/ https://ncbi.nlm.nih.gov/pubmed/24476519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5858/arpa.2013-0056-OA |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|